Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tracking myeloma tumor DNA in peripheral blood.

Best practice & research. Clinical haematology - 1 Mar 2020

Waldschmidt Johannes M, Vijaykumar Tushara, Knoechel Birgit, Lohr Jens G

Abstract excerpt

Over the past years, the emergence of liquid biopsy technologies has dramatically expanded our ability to assess multiple myeloma without the need for invasive sampling. Interrogation of cell-free DNA from the peripheral blood recapitulates the mutational landscape at excellent concordance with matching bone marrow aspirates. It can quantify disease burden and identify previously undetected resistance mechanisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Plasma Cells
Share to Neoplasm, Residual
Share to Circulating Tumor DNA

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to GTP Phosphohydrolases

Share to Liquid Biopsy

Share to Multiple Myeloma

Share to Proto-Oncogene Proteins p21(ras)

Share to Recurrence

Source

Open in PubMed Open full text

Identifiers

PMID: 32139012
DOI: 10.1016/j.beha.2020.101146
PMCID: PMC7060910

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tracking myeloma tumor DNA in peripheral blood.PMID 32139012Read ↗

Circulating Tumour DNA for Detecting Minimal Residual Disease in Multiple MyelomaSemantic proximity Read ↗

Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities.Semantic proximity Read ↗

Clinical Implications of Circulating Tumor DNA in Multiple Myeloma and Its Precursor DiseasesSemantic proximity Read ↗

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read ↗

Circulating Tumour DNA Analysis for Tumour Genome Characterisation and Monitoring Disease Burden in Extramedullary Multiple Myeloma.Semantic proximity Read ↗

Analysis of Circulating Tumor DNA.Semantic proximity Read ↗

Cell-free DNA Whole Genome Sequencing for Non-Invasive Minimal Residual Disease Detection in Multiple MyelomaSemantic proximity Read ↗

Deciphering response dynamics and treatment resistance from circulating tumor DNA after CAR T-cells in multiple myelomaSemantic proximity Read ↗

Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencingSemantic proximity Read ↗

Liquid biopsies for multiple myeloma in a time of precision medicineSemantic proximity Read ↗

Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma.Semantic proximity Read ↗

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.